Drug intelligence / Profile preview

iG-Tregs

Development stage
Phase 2
Lead developer
University of Patras
Modality
Cell Therapies
Administration
Intravenous
01

Overview

iG-Tregs (induced GvHD-specific regulatory T cells) is an investigational adoptive cell therapy developed by the University of Patras for the prevention and treatment of graft-versus-host disease (GvHD) following hematopoietic stem cell transplantation. The therapy consists of donor-derived CD4+ T cells that are induced ex vivo into a regulatory T cell (Treg) phenotype, characterized by the expression of the transcription factor FOXP3. The induction process typically utilizes a specialized culture protocol involving TGF-beta and pharmacological agents like rapamycin to generate a stable and functional suppressive cell population. These induced Tregs are designed to suppress the activation and proliferation of alloreactive donor T cells that attack host tissues, thereby mitigating GvHD while potentially preserving the beneficial graft-versus-tumor effect.

Other names
induced regulatory T cellsinduced GvHD-specific regulatory T cellsinduced GvHD-specific Tregs
02

Targets

NeuraminidaseHLA-G (Human leukocyte antigen G)IL-2 (Interleukin 2)

Beyond the preview

Go deeper on iG-Tregs.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iG-Tregs.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call